Accordingly, (R)-PFI-2 treatment of mouse embryonic fibroblasts (MEFs) and human BC MCF7 cell lines enhanced the stability and nuclear localization of YAP, as well as augmented the expression of YAP1 transcriptional targets [76]. The gene discussed is YAP1; the disease is breast cancer.